共 50 条
- [1] Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance ACS INFECTIOUS DISEASES, 2024, 10 (04): : 1174 - 1184
- [7] Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern? MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 32 : 263 - 266
- [8] SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (06): : 2769 - 2784
- [10] An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV-2 Mpro ACS BIO & MED CHEM AU, 2024, 4 (06): : 280 - 290